Biochimica et Biophysica Acta 2004-03-17

Induction of cytokines by toxins that have an identical RNA N-glycosidase activity: Shiga toxin, ricin, and modeccin.

Chisato Yamasaki, Kiyotaka Nishikawa, Xun-Ting Zeng, Yukie Katayama, Yumiko Natori, Nobukazu Komatsu, Tatsuya Oda, Yasuhiro Natori

Index: Biochim. Biophys. Acta 1671(1-3) , 44-50, (2004)

Full Text: HTML

Abstract

Shiga toxin (Stx) has an A1-B5 subunit structure, and the A subunit is an RNA N-glycosidase that inhibits cellular protein synthesis. We previously reported that in Caco-2 cells Stx induced cytokines and that the RNA N-glycosidase activity was essential for the cytokine induction. It is known that the binding of the Stx-B subunit to its receptor glycolipid, Gb3, mediates an A subunit-independent signal in some types of cells, but the involvement of this signal in the cytokine induction is unclear. In this study, we investigated whether RNA N-glycosidase itself induces cytokines. IL-8 production was enhanced by Stx, ricin, and modeccin, three toxins that inhibit protein synthesis through an identical RNA N-glycosidase activity, but not by two other types of protein synthesis inhibitors, diphtheria toxin and cycloheximide. The RNA N-glycosidase-type toxins showed a similar induction pattern of cytokine mRNAs. Brefeldin A, a Golgi apparatus inhibitor, completely suppressed the cytokine induction by the toxins. Analysis by using inhibitors of toxin binding and also Stx-B subunit showed that the cytokine-inducing activity was independent of Gb3-mediated signaling. These results indicate that RNA N-glycosidase itself induces the cytokine production and that intracellular transport of toxins through the Golgi apparatus is essential for the activity.


Related Compounds

  • Lyso-Globotriaosy...

Related Articles:

LC–MS/MS analysis of plasma lyso-Gb3 in Fabry disease

2012-12-24

[Clin. Chim. Acta 414 , 273-80, (2012)]

A metabolomic study reveals novel plasma lyso-Gb3 analogs as Fabry disease biomarkers.

2013-01-01

[Curr. Med. Chem. 20(2) , 280-8, (2013)]

In vivo tumor targeting using a novel intestinal pathogen-based delivery approach.

2006-07-15

[Cancer Res. 66(14) , 7230-6, (2006)]

Plasma globotriaosylsphingosine as a biomarker of Fabry disease.

2010-07-01

[Mol. Genet. Metab. 100(3) , 257-61, (2010)]

Quantification of the Fabry marker lysoGb3 in human plasma by tandem mass spectrometry.

2012-02-01

[J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 883-884 , 128-35, (2012)]

More Articles...